Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Assess the Safety of ELGN-2112 in Preterm Infants Born Under 26 Weeks GA and IUGR Infants Born 26-32 Weeks GA

Study ID: NCT05904626
Start Date: 2025-05
End Date: 2027-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

ELGN-2112

Placebo

Sponsor

Elgan Pharma Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma

Study ID: NCT06883526
Start Date: 2025-05
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

ZG005 for Injection

Gecacitinib Hydrochloride Tablets

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Source: clinicaltrials.gov

Share:
Add to list

Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning from Home Training in Individuals with Spinocerebellar Ataxia

Study ID: NCT06177626
Start Date: 2025-07-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Aerobic Training

Balance Training

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer

Study ID: NCT06791057
Start Date: 2025-07-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

420

Intervention / Treatment

Dyspnea Intervention

Enhanced Usual Care

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Study ID: NCT06451757
Start Date: 2025-08-02
End Date: 2028-01-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Sonlicromanol

Placebo

Sponsor

Khondrion BV

Source: clinicaltrials.gov

Share:
Add to list

Multi-Center Clinical Trial of Shenling Baizhu Granules for Preventing Low-Risk Colorectal Adenoma Recurrence

Study ID: NCT06930157
Start Date: 2025-07-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

624

Intervention / Treatment

S is very smart B loves the master granules (TC M patent medicine)

Sponsor

Shanghai Jiao Tong University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women Who Have Started Their Periods

Study ID: NCT06904274
Start Date: 2025-06-02
End Date: 2026-10-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

BAY865028

Medroxyprogesterone acetate

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Study ID: NCT06124157
Start Date: 2025-05-29
End Date: 2030-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

680

Intervention / Treatment

Biospecimen Collection

Blinatumomab

Bone Marrow Biopsy

CALASPARGASE PEGOL

Cyclophosphamide

Cytarabine

Underlined

Etrorior

Doxorubicin

Echocardiography Test

Leucovorin

Mercaptopurine

Methotrexate

Multigated Acquisition Scan

Pegaspargase

Prednisolone

Prednisone

Radiation Therapy

Thioguanine

Vincristine

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI

Study ID: NCT05114057
Start Date: 2025-12-01
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1380

Intervention / Treatment

Renal Angina Index (RAI)

Sponsor

Children's Hospital Medical Center, Cincinnati

Source: clinicaltrials.gov

Share:
Add to list

Carotid Implants for PreveNtion of STrokE ReCurrEnce from Large Vessel Occlusion in Atrial Fibrillation Patients Treated with Oral Anticoagulation

Study ID: NCT05723926
Start Date: 2025-09-20
End Date: 2030-10-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Vine Filter

Sponsor

Javelin Medical

Source: clinicaltrials.gov

Share:
Add to list